Experience with dalbavancin for cellulitis in the emergency department and emergency observation unit
- 1 July 2018
- journal article
- letter
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 36 (7) , 1312-1314
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Clinical pathway for moderate to severe acute bacterial skin and skin structure infections from a US perspective: a roundtable discussionHospital Practice, 2016
- Clinical efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI)Therapeutics and Clinical Risk Management, 2016
- Economic Impact of Oritavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in the Emergency Department or Observation Setting: Cost Savings Associated with Avoidable HospitalizationsClinical Therapeutics, 2016
- A Randomized Clinical Trial of Single-Dose Versus Weekly Dalbavancin for Treatment of Acute Bacterial Skin and Skin Structure InfectionClinical Infectious Diseases, 2015
- Assessing the economic value of avoiding hospital admissions by shifting the management of gram+ acute bacterial skin and skin-structure infections to an outpatient care settingJournal of Medical Economics, 2015
- Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2014
- Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin InfectionNew England Journal of Medicine, 2014
- PIN22 Economic Burden of Hospitalization With Antibiotic Treatment for Absssi in the United States: An Analysis Ofthe Premier Hospital DatabaseValue in Health, 2012
- Bacterial Skin and Soft Tissue Infections in Adults: A Review of Their Epidemiology, Pathogenesis, Diagnosis, Treatment and Site Of CareCanadian Journal of Infectious Diseases and Medical Microbiology, 2007
- Managing skin and soft tissue infections: expert panel recommendations on key decision pointsJournal of Antimicrobial Chemotherapy, 2003